BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian germ cell tumor AND MUC16, CA125, CA-125 AND Prognosis
27 results:

  • 1. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 2. Fortuitously detected primary ovarian carcinoid tumor: A case report.
    Choi HY; Pak MG; Park JW
    Medicine (Baltimore); 2023 Aug; 102(31):e34391. PubMed ID: 37543794
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary pure large cell neuroendocrine carcinoma of the ovary: A rare case report and review of literature.
    Peng X; Wang H
    Medicine (Baltimore); 2020 Dec; 99(49):e22474. PubMed ID: 33285672
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Preoperative Differentiation of Benign and Malignant Non-epithelial ovarian tumors: Clinical Features and tumor Markers.
    Gomes TA; Campos EA; Yoshida A; Sarian LO; Andrade LALA; Derchain SF
    Rev Bras Ginecol Obstet; 2020 Sep; 42(9):555-561. PubMed ID: 32992358
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gallbladder neuroendocrine carcinoma: A single center experience.
    Chu H; Zhang C; Shi Y; Wu W; Hu Z; Zhang J; Huang D
    Medicine (Baltimore); 2020 Sep; 99(36):e21912. PubMed ID: 32899024
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Gynecologic cancer in pregnancy.
    Korenaga TK; Tewari KS
    Gynecol Oncol; 2020 Jun; 157(3):799-809. PubMed ID: 32268951
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clear cell gynecologic carcinomas: about 5 cases.
    Haifa B; Ines Z; Manel N; Amira D; Sonia Z; Laila N; Houda M; Anis H; Raja F
    Pan Afr Med J; 2019; 34():87. PubMed ID: 31934230
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Peritoneal Nodules in a Pediatric Patient with Benign Teratoma. A Case Report and Review of Literature.
    Badru F; Saxena S; Munoz-Abraham AS; Guzman MA; Bansal S; Chatoorgoon K
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):632-636. PubMed ID: 29990549
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The role of preoperative serum cancer antigen 125 in malignant ovarian germ cell tumors.
    Kim JH; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):236-240. PubMed ID: 29673667
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mature Teratoma Associated with Bilateral ovarian Carcinosarcoma - Accidental Association or Etiopathogenetic Determinism? - Case Report.
    Birla R; Catanescu ER; Caragui A; Constantinoiu S;
    Chirurgia (Bucur); 2016; 111(5):422-427. PubMed ID: 27819640
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pediatric ovarian neoplastic tumors: incidence, age at presentation, tumor markers and outcome.
    Taskinen S; Fagerholm R; Lohi J; Taskinen M
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):425-9. PubMed ID: 25640522
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Clinical study on 68 cases with struma ovarii].
    Wang Y; Pan L; Huang H; Shen K; Wu M; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):451-4. PubMed ID: 25169639
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Squamous cell carcinoma arising in mature cystic teratoma (dermoid cyst)--a rare presentation.
    Chaudhry S; Hussain R
    J Pak Med Assoc; 2013 Apr; 63(4):521-3. PubMed ID: 23905455
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. tumor markers in clinical practice: a review focusing on common solid cancers.
    Duffy MJ
    Med Princ Pract; 2013; 22(1):4-11. PubMed ID: 22584792
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
    Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
    Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. prognosis and treatment of squamous cell carcinoma from a mature cystic teratoma of the ovary.
    Chen RJ; Chen KY; Chang TC; Sheu BC; Chow SN; Huang SC
    J Formos Med Assoc; 2008 Nov; 107(11):857-68. PubMed ID: 18971155
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
    Salonen J; Leminen A; Stenman UH; Butzow R; Heikinheimo M; Heikinheimo O
    Tumour Biol; 2008; 29(1):50-6. PubMed ID: 18497549
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.
    Abe A; Furumoto H; Yoshida K; Nishimura M; Irahara M; Kudo E; Sano T
    Int J Gynecol Cancer; 2008; 18(1):168-72. PubMed ID: 17466041
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis.
    Hirabayashi K; Yasuda M; Osamura RY; Hirasawa T; Murakami M
    Gynecol Oncol; 2006 Jul; 102(1):111-7. PubMed ID: 16527336
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evidence for the clinical use of tumour markers.
    Duffy MJ
    Ann Clin Biochem; 2004 Sep; 41(Pt 5):370-7. PubMed ID: 15333188
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.